CS235976B2 - Method of pyrimidine derivatives production - Google Patents
Method of pyrimidine derivatives production Download PDFInfo
- Publication number
- CS235976B2 CS235976B2 CS829474A CS947482A CS235976B2 CS 235976 B2 CS235976 B2 CS 235976B2 CS 829474 A CS829474 A CS 829474A CS 947482 A CS947482 A CS 947482A CS 235976 B2 CS235976 B2 CS 235976B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- group
- methyl
- ethyl
- pyridyl
- residue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33478481A | 1981-12-28 | 1981-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS235976B2 true CS235976B2 (en) | 1985-05-15 |
Family
ID=23308823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS829474A CS235976B2 (en) | 1981-12-28 | 1982-12-21 | Method of pyrimidine derivatives production |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0083186B1 (pt) |
| JP (1) | JPS58118585A (pt) |
| KR (1) | KR860000106B1 (pt) |
| AT (1) | ATE34173T1 (pt) |
| AU (1) | AU558153B2 (pt) |
| CA (1) | CA1206151A (pt) |
| CS (1) | CS235976B2 (pt) |
| DD (1) | DD203720A5 (pt) |
| DE (1) | DE3278473D1 (pt) |
| DK (1) | DK574782A (pt) |
| ES (1) | ES8403895A1 (pt) |
| FI (1) | FI824407L (pt) |
| GB (1) | GB2111995B (pt) |
| GR (1) | GR78415B (pt) |
| HU (1) | HU192951B (pt) |
| IE (1) | IE54313B1 (pt) |
| IL (1) | IL67496A (pt) |
| NZ (1) | NZ202797A (pt) |
| PH (1) | PH19797A (pt) |
| PL (1) | PL239796A1 (pt) |
| PT (1) | PT76004B (pt) |
| SU (1) | SU1195906A3 (pt) |
| ZA (1) | ZA829247B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468399A (en) * | 1981-12-28 | 1984-08-28 | Eli Lilly And Company | 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones |
| GB8320505D0 (en) * | 1983-07-29 | 1983-09-01 | Smith Kline French Lab | Chemical compounds |
| US4772704A (en) * | 1983-09-21 | 1988-09-20 | Bristol-Myers Company | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |
| GB8421427D0 (en) * | 1984-08-23 | 1984-09-26 | Smith Kline French Lab | Chemical compounds |
| TW245716B (pt) * | 1992-12-28 | 1995-04-21 | Takeda Pharm Industry Co | |
| RU2250767C1 (ru) * | 2004-07-12 | 2005-04-27 | Казанский государственный медицинский университет | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки |
| CN102260254A (zh) * | 2010-05-31 | 2011-11-30 | 中国农业科学院植物保护研究所 | 新颖2-硝基亚氨基嘧啶衍生物的合成 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1421792A (en) * | 1973-05-17 | 1976-01-21 | Smith Kline French Lab | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
| IN146736B (pt) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab | |
| US4200578A (en) * | 1978-12-18 | 1980-04-29 | Bristol-Myers Company | Thiazole derivatives |
| US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
| AU531142B2 (en) * | 1979-04-04 | 1983-08-11 | Smith Kline & French Laboratories Limited | 2 amino- pyimindones |
| US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
-
1982
- 1982-12-14 NZ NZ202797A patent/NZ202797A/en unknown
- 1982-12-14 CA CA000417662A patent/CA1206151A/en not_active Expired
- 1982-12-15 PH PH28281A patent/PH19797A/en unknown
- 1982-12-15 AU AU91539/82A patent/AU558153B2/en not_active Ceased
- 1982-12-15 ZA ZA829247A patent/ZA829247B/xx unknown
- 1982-12-16 IL IL67496A patent/IL67496A/xx unknown
- 1982-12-20 DE DE8282306785T patent/DE3278473D1/de not_active Expired
- 1982-12-20 PT PT76004A patent/PT76004B/pt unknown
- 1982-12-20 AT AT82306785T patent/ATE34173T1/de active
- 1982-12-20 GB GB08236116A patent/GB2111995B/en not_active Expired
- 1982-12-20 EP EP82306785A patent/EP0083186B1/en not_active Expired
- 1982-12-21 CS CS829474A patent/CS235976B2/cs unknown
- 1982-12-21 IE IE3031/82A patent/IE54313B1/en unknown
- 1982-12-21 FI FI824407A patent/FI824407L/fi not_active Application Discontinuation
- 1982-12-23 GR GR70164A patent/GR78415B/el unknown
- 1982-12-24 SU SU823526201A patent/SU1195906A3/ru active
- 1982-12-27 DK DK574782A patent/DK574782A/da not_active Application Discontinuation
- 1982-12-27 HU HU824173A patent/HU192951B/hu not_active IP Right Cessation
- 1982-12-27 ES ES518592A patent/ES8403895A1/es not_active Expired
- 1982-12-28 PL PL23979682A patent/PL239796A1/xx unknown
- 1982-12-28 DD DD82246677A patent/DD203720A5/de unknown
- 1982-12-28 KR KR8205837A patent/KR860000106B1/ko not_active Expired
- 1982-12-28 JP JP57234881A patent/JPS58118585A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0083186B1 (en) | 1988-05-11 |
| EP0083186A3 (en) | 1984-05-23 |
| KR840002831A (ko) | 1984-07-21 |
| FI824407A7 (fi) | 1983-06-29 |
| JPS58118585A (ja) | 1983-07-14 |
| IE823031L (en) | 1983-06-28 |
| PT76004A (en) | 1983-01-01 |
| ATE34173T1 (de) | 1988-05-15 |
| PL239796A1 (en) | 1984-05-21 |
| GR78415B (pt) | 1984-09-27 |
| IL67496A (en) | 1986-11-30 |
| EP0083186A2 (en) | 1983-07-06 |
| IE54313B1 (en) | 1989-08-16 |
| ZA829247B (en) | 1984-07-25 |
| DD203720A5 (de) | 1983-11-02 |
| PT76004B (en) | 1985-12-03 |
| KR860000106B1 (ko) | 1986-02-19 |
| AU9153982A (en) | 1983-07-07 |
| PH19797A (en) | 1986-07-02 |
| GB2111995A (en) | 1983-07-13 |
| GB2111995B (en) | 1985-07-24 |
| FI824407L (fi) | 1983-06-29 |
| HU192951B (en) | 1987-08-28 |
| CA1206151A (en) | 1986-06-17 |
| NZ202797A (en) | 1985-08-30 |
| SU1195906A3 (ru) | 1985-11-30 |
| DK574782A (da) | 1983-06-29 |
| ES518592A0 (es) | 1984-04-01 |
| DE3278473D1 (en) | 1988-06-16 |
| AU558153B2 (en) | 1987-01-22 |
| FI824407A0 (fi) | 1982-12-21 |
| ES8403895A1 (es) | 1984-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1442024B1 (en) | AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS | |
| CN112533904B (zh) | 黑皮质素亚型-2受体(mc2r)拮抗剂及其用途 | |
| DE60118704T2 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
| KR850001795B1 (ko) | 2,4-이치환된 티아졸 유도체의 제조방법 | |
| DE69208263T2 (de) | Substituierte aminopyrimidine als angiotensin ii antagonisten | |
| CS200545B2 (en) | Method of producing derivatives of guanidine | |
| DD201901A5 (de) | Verfahren zur herstellung neuer derivate von 4-amino-6,7-dimethoxy-2-piperazinochinazolin | |
| DE3689748T2 (de) | Benzimidazolderivate, Verfahren zu deren Herstellung und deren therapeutische Anwendung. | |
| KR20040048920A (ko) | 글리코겐 신타아제 키나제 3-베타 저해제(ｇｓｋ저해제)로서의 헤테로아릴 아민 | |
| SI9520084A (en) | Use of heterocyclic compounds as dopamines-d3 ligands | |
| BG63500B1 (bg) | Триазолови съединения и тяхното използване | |
| DE69724098T2 (de) | Chinolin- und benzimidazolderivate als bradykinin agonisten | |
| NO841168L (no) | Fremgangsmaate for fremstilling av pyrimidinderivater | |
| AU2001259691B2 (en) | Modulators of TNF-alpha signaling | |
| CN114728949B (zh) | 作为激酶抑制剂的杂环化合物及其用途 | |
| JP2023541203A (ja) | Ｔｙｋ２阻害剤およびその使用 | |
| DE2658267A1 (de) | Pyrimid-4-on- und -thion-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| EP0196005A1 (de) | Pyridazinone, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| AU2001259691A1 (en) | Modulators of TNF-alpha signaling | |
| PT77855B (en) | Pyridine derivatives | |
| NZ207914A (en) | Indeno-pyridazinones and pharmaceutical compositions | |
| US3169966A (en) | Aminopyrazoles | |
| EP0068833A2 (en) | Pyrimidinone derivatives and pharmaceutical compositions containing them | |
| CA3176142A1 (en) | Phd inhibitor compounds, compositions, and use | |
| DD202552A5 (de) | Heterocyclische derivate |